Crosstalk between IL-6/JAK/STAT3 and TNF-α/NF-κB signaling in colitis-associated colorectal cancer: epigenetic reprogramming, evidence boundaries, and opportunities for disease management.

Yuan J, Liao J, Li F, Xie D, Zuo Z, Zhang D, Zhang T

Open source

DOI
10.3389/fimmu.2026.1979583
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1979583,
  title = {Crosstalk between IL-6/JAK/STAT3 and TNF-α/NF-κB signaling in colitis-associated colorectal cancer: epigenetic reprogramming, evidence boundaries, and opportunities for disease management.},
  author = {Yuan J and Liao J and Li F and Xie D and Zuo Z and Zhang D and Zhang T},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1979583},
  url = {https://doi.org/10.3389/fimmu.2026.1979583}
}

RIS

TY  - JOUR
TI  - Crosstalk between IL-6/JAK/STAT3 and TNF-α/NF-κB signaling in colitis-associated colorectal cancer: epigenetic reprogramming, evidence boundaries, and opportunities for disease management.
AU  - Yuan J
AU  - Liao J
AU  - Li F
AU  - Xie D
AU  - Zuo Z
AU  - Zhang D
AU  - Zhang T
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1979583
UR  - https://doi.org/10.3389/fimmu.2026.1979583
ER  - 

APA

J, Y., J, L., F, L., D, X., Z, Z., D, Z., & T, Z. (2026). Crosstalk between IL-6/JAK/STAT3 and TNF-α/NF-κB signaling in colitis-associated colorectal cancer: epigenetic reprogramming, evidence boundaries, and opportunities for disease management.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1979583

Source records